The Cell Line Development Market is being driven by Increased demand for monoclonal antibodies
The Cell Line Development Market is expected to grow at a CAGR of 14.63% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 7.41 billion. In the current market landscape, laboratories are under pressure to increase volume while maintaining high-quality, error-free results due to decreasing profitability per test. This trend is driving the adoption of automated systems for cell line development technology. In the US, the influx of insured patients and the need for efficient workflow solutions have further encouraged automation. Cell line development technologies have proven to be valuable tools for health and research centers, enabling advancements in cancer research, drug screening, and cytotoxicity studies, among others. By investing in automated systems, laboratories can streamline their processes, improve accuracy, and enhance overall productivity.
Get more information on Cell Line Development Market by requesting a sample report
The market is segmented based on
According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows:
However, the market also witnesses some limitations, which are as follows:
Rich Experience: 20+ years leading global market research, trusted insights across industries.
Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.
Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.
Market Scope |
|
Report Coverage |
Details |
Page number |
163 |
Base year |
2023 |
Historic period |
2018-2022 |
Forecast period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 14.63% |
Market growth 2024-2028 |
USD 7.41 billion |
Market structure |
market_structure.ucfirst |
YoY growth 2023-2024(%) |
13.59 |
Key countries |
US, Germany, UK, China, and Japan |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Find out which segment is leading the market by accessing the free PDF report
The Cell Line Development Market encompasses the production and supply of cell lines, media, and reagents to diagnostic laboratories, biopharma businesses, and research institutions. This market caters to various sectors including drug discovery, cancer therapies, vaccine research, and monoclonal antibody production for blockbuster medications. In low-income countries, primary cell lines and recombinant cell lines are increasingly being used to advance research and development in these areas. Recombinant monoclonal antibodies play a crucial role in this market, with applications in diagnostics, therapeutics, and research.
The Cell Line Development Market is a significant segment of the global Life Sciences Tools and Services Market, estimated to be worth USD132.53 billion in 2023. This market encompasses diagnostic laboratories, pharmaceutical and biotech companies, and research organizations involved in the research and development of various product categories, including diagnostic media and reagents, monoclonal antibodies, primary and recombinant cell lines. Technavio's market analysis covers manufacturers of equipment, supplies, and services for research and development in the pharmaceutical and biotech industries, as well as laboratory diagnosis services. Key product categories include capital equipment, instruments, accessories, consumables, contract research, contract manufacturing, and contract sales. The market is expected to grow moderately during the forecast period.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
Safe and Secure SSL Encrypted